FLT3 and acute myeloid leukemia: In addition, it displayed potent in vitro activity in 8 of 10 non-MLL-rearranged patient AML samples, including those with mutant NPM1 or internal tandem duplication of the juxtamembrane domain-coding sequence of the FLT3 gene (FLT3-ITD).